Does SAPROPTERIN Cause Neoplasm malignant? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Neoplasm malignant have been filed in association with SAPROPTERIN (JAVYGTOR). This represents 0.1% of all adverse event reports for SAPROPTERIN.
6
Reports of Neoplasm malignant with SAPROPTERIN
0.1%
of all SAPROPTERIN reports
2
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm malignant From SAPROPTERIN?
Of the 6 reports, 2 (33.3%) resulted in death, 1 (16.7%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SAPROPTERIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does SAPROPTERIN Cause?
Drug ineffective (356)
Therapy non-responder (348)
Headache (309)
Maternal exposure during pregnancy (277)
Vomiting (260)
Diarrhoea (238)
Amino acid level increased (194)
Nausea (189)
Abdominal pain upper (179)
Anxiety (174)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which SAPROPTERIN Alternatives Have Lower Neoplasm malignant Risk?
SAPROPTERIN vs SAQUINAVIR
SAPROPTERIN vs SARECYCLINE
SAPROPTERIN vs SARGRAMOSTIM
SAPROPTERIN vs SARILUMAB
SAPROPTERIN vs SATRALIZUMAB